More on SRPT
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $16.23 |
|
|||
| Open | $15.86 | ||||
| 52 Wk High | $63.73 | ||||
| 52 Wk Low | $8.00 | ||||
| Day High | $16.88 | ||||
| Day Low | $15.53 | ||||
| P/E | N/A | ||||
| EPS | $-5.69 | ||||
| Volume | 3,064,037 | ||||
- Form 4 Sarepta Therapeutics, For: Mar 02 Filed by: Rothfuss Cristin
- Form 4 Sarepta Therapeutics, For: Mar 02 Filed by: Wong Ryan Ho-Yan
- Form 4 Sarepta Therapeutics, For: Mar 01 Filed by: Estepan Ian Michael
- Form 4 Sarepta Therapeutics, For: Mar 01 Filed by: Rodino-Klapac Louise
- Sarepta Therapeutics (SRPT) PT Raised to $25 at Freedom Capital Markets
- Jefferies Reiterates Buy Rating on Sarepta Therapeutics (SRPT); cites as potential "recovery story"
- Form 4 Sarepta Therapeutics, For: Feb 26 Filed by: Estepan Ian Michael
- Form 10-K Sarepta Therapeutics, For: Dec 31
- Sarepta Therapeutics (SRPT) PT Lowered to $29 at Wedbush
- Form 4 Sarepta Therapeutics, For: Feb 25 Filed by: Estepan Ian Michael
Entities mentioned with SRPT
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Definitive Agreement | View Related Stories »
- Needham & Company | View Related Stories »
- Show More...
